Authors
Latest:
John Green: "Tuberculosis Anywhere Is a Threat to People Everywhere"Tuberculosis is a long-standing global health issue that requires continued public health vigilance to prevent a resurgence of this preventable and curable disease.
Latest:
Managing AEs With BTK Inhibitors in CLLLisa Nodzon, PhD, ARNP, AOCNP; Katie Tobon, PharmD, BCOP; and Javier Pinilla-Ibarz, MD, PhD, share insight on strategies for the monitoring and management of BTK inhibitor–associated toxicities in CLL and review the importance of a multidisciplinary approach to treatment.
Latest:
Nuclear Isotopes Could Help Address Challenges in Oncology Clinical TrialsThe radiation emerging from these isotopes can be used in 2 different ways in cancer trials: imaging (detection of tumors) and therapy (destruction of tumors).
Latest:
Evaluating Compounding Compliance Coming Out of the COVID-19 FogAs pharmacists were pulled into patient-facing roles, many hospitals were forced to scale back or make adjustments in medication compounding practices.
Latest:
Factor XI Inhibitors: The Future of AnticoagulationFactor XI inhibitors show promise as a safer alternative to direct oral anticoagulants for preventing and treating thrombosis, offering similar efficacy with reduced bleeding risk.
Latest:
Updated Cardiovascular Guidelines for Individuals with HIV Expand Statin EligibilityMedication therapy management reimbursement can be a driving factor to work toward statin implementation in this patient group.
Latest:
Five Tips for a Successful Transition From the Third to Fourth Year of Pharmacy SchoolStudents should ask questions and stay engaged in their education.
Latest:
When to Call, When to Counsel: Acetazolamide for Idiopathic Intracranial HypertensionIdiopathic intracranial hypertension was previously considered a rare condition, however, its prevalence is increasing in parallel with obesity in patient populations.
Latest:
The UK Became a Leader in the Cell Therapy Revolution, but a Lack of Ongoing Investment Could Change ThatAdvanced cell therapies are now saving the lives of people whose blood cancer would previously have been incurable. While the UK was quick to recognize the potential of these innovative therapies, patient access to these therapies may change without continued investment in the UK's cell therapy infrastructure.
Latest:
Comparative Oncology: Advances in Cancer Care from Pets to HumansDogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.
Latest:
Exploring the Vascular Benefits of Semaglutide in Peripheral Artery DiseaseMarc Bonaca, MD, PHH, FACC discussed semaglutide’s potential benefits for non-diabetic patients with peripheral artery disease.
Latest:
Fourth-Year Pharmacy Students Help Patients and Practitioners in Transitional CareStudents are being exposed to new patient experiences through collaboration with practitioners.
Latest:
Pharmacy-Led Medication Reconciliation Is Best PracticeThe TJC and IHI advocate for medication reconciliation at all transitions of care.
Latest:
Three Trends Shaping HIV Pharmacy CareAlthough quality of life has significantly improved for patients with HIV, there are several factors influencing how we provide care and treat patients now and in the future.
Latest:
AAN 2025: Tolebrutinib Shows Promise in Slowing Disability Progression for Secondary Progressive Multiple SclerosisThe HERCULES trial demonstrates tolebrutinib's potential to slow disability progression in non-relapsing secondary progressive multiple sclerosis, offering a new treatment option for patients with limited therapeutic choices.
Latest:
Metronidazole Twice Daily: A Pharmacokinetic and Clinical JustificationThis medication is associated with a number of adverse effects, such as gastrointestinal upset and peripheral neuropathies, that may be mitigated by less frequent dosing.
Latest:
To Deliver Cell and Gene Therapies to More Patients, Innovation in Diagnostic Testing is EssentialIndividualized treatments like cell and gene therapies are poised to scale rapidly over the next decade.
Latest:
Finerenone Shows Promise in Heart Failure and Kidney Disease ManagementJohn Ostrominski, MD shares insights into the safety and efficacy of finerenone, based on data from the FINEARTS-HF trial.
Latest:
Treating Acid Reflux With Over-the-Counter MedicationsAn overview of acid reflux and gastroesophageal reflux disease, over-the-counter options, long-term effects of proton pump inhibitors, lifestyle recommendations, and when to refer patients.
Latest:
Marcella Kinaya, PharmD, on Flu Season: ‘We’re Here to Protect People and Make Sure They’re Healthy’A district leader at CVS Health emphasizes that patients should get tested, be up to date with immunizations, and staying home and reach out to health care professionals when experiencing symptoms.
Latest:
Improving Medication Guidance Needs to be a Top Priority for Hospitals, Health SystemsMore drugs plus a growing population of older and sicker patients is creating medication-alert overload for already stressed clinicians.
Latest:
Innovative Strategies in Residency Training: Approaching Competencies, Quality Improvement, and AI IntegrationIncorporating AI into pharmacy education is crucial to training on its appropriate use.
Latest:
Case Study: Pharmacist Management of Inappropriate Prednisone Dosing Triggered By AsthmaHolistic and compassionate counseling by a pharmacist and pharmacy-interns on-duty over weekends could positively impact patient lives, especially for older adults and economically disadvantaged patients.
Latest:
Ambulatory Care Pharmacist-Administered Depression Screenings Can Close Gaps in CareThe study implemented a novel workflow for ambulatory care pharmacists to execute pharmacist-administered depression screenings.
Latest:
USC ALL Induction Regimen Combined With Newer TKIs Is Safe, Effective for Patients With Ph+ DiseaseAchieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.
Latest:
A Pharmacist’s Guide to Lung Cancer and Its Key TreatmentsThough new treatments offer hope, careful monitoring and understanding of risks remain essential for their success.
Latest:
The Tao of Tau: Developing the “My Vancomycin Calculator” AppCreating a free app to assist in vancomycin dosing proved to be an entertaining and enlightening journey.
Latest:
Consider the Commissioned Corps of the United States Public Health Service for a Rewarding Pharmacy CareerWorking for the USPHS offers unique compensation and quality-of-life benefits.
Latest:
Driving Clinical Pharmacy Development With Data-Driven Metrics and InsightsThere are no clearly defined, widely accepted clinical pharmacist metrics.
